TL;DR
Researchers have used cryo-electron microscopy (cryo-EM) to solve the structure of the relaxin receptor (RXFP1), revealing a surprising "autoinhibition" mechanism. Unlike most receptors that are toggled "on" directly by a ligand, RXFP1 is pre-loaded with an internal activator that is physically blocked by its own outer domains until the hormone relaxin-2 arrives to move them out of the way.
What Problem Does This Paper Address?
The relaxin family peptide receptor 1 (RXFP1) is a major player in human physiology, regulating everything from cardiovascular health to the remodeling of tissues during pregnancy. It is a complex, multi-domain G protein-coupled receptor (GPCR) belonging to the leucine-rich repeat-containing (LGR) family.
For years, scientists were puzzled by how RXFP1 actually signals. Other members of its family (like the luteinizing hormone receptor) are activated by massive glycoprotein hormones that use a "push-pull" physical mechanism to trigger the receptor. However, the hormone relaxin-2 is tiny (only 6 kDa) by comparison—far too small to exert that kind of mechanical force. Furthermore, RXFP1 possesses a unique "LDLa" module at its tip that is essential for signaling but whose role remained a total mystery. This paper sought to uncover the structural blueprint of RXFP1 to explain this unconventional activation.
Methods
The team employed a multi-disciplinary "tour de force" to crack the code:
- Cryo-EM: They determined the structure of the active-state human RXFP1 bound to an engineered relaxin-2 and a heterotrimeric $G_s$ protein. To stabilize the notoriously flexible receptor, they used a "mini-$G_s$" fusion protein.
- Evolutionary Coupling (EC) Analysis: By analyzing thousands of related sequences, they identified pairs of amino acids that "co-evolve." This allowed them to predict which parts of the receptor touch each other in the inactive state, which is difficult to capture via imaging alone.
- Molecular Dynamics (MD) Simulations: They ran high-performance computer simulations to observe the receptor's "wiggle" and confirm how specific mutations affect its transition from off to on.
- Crosslinking Mass Spectrometry (CLMS): This technique acted like "molecular glue," mapping exactly where the relaxin-2 hormone anchors itself to the receptor's outer domain.
Datasets
- Structural Data: The primary outputs are the high-resolution maps deposited in the Protein Data Bank (PDB: 7TMW) and Electron Microscopy Data Bank (EMDB: 26003, 26004).
- Sequence Data: For evolutionary coupling, the authors utilized the UniRef100 database to build massive multiple sequence alignments (over 350,000 sequences).
Key Insights and Ideas
- The Tethered Agonist: The most shocking find was that RXFP1’s own extracellular loop 2 (ECL2) acts as an internal activator. In the active state, this loop dives deep into the receptor's core to trigger signaling.
- The Autoinhibition Model: In its resting state, the receptor's large outer domain (the LRRs) and a "hinge" region physically block ECL2 from entering the signaling pocket. The receptor is essentially "self-inhibited."
- Relaxin-2 as a "Remover": Relaxin-2 doesn't actually touch the signaling pocket. Instead, it binds to the outer LRR domain and causes it to shift. This movement "unblocks" the internal ECL2 loop, allowing it to drop into the pocket and turn the receptor "on."
- The Conserved CΦPΦ Motif: The researchers identified a specific sequence motif in the ECL2 loop that is conserved across the LGR family, suggesting that this "internal trigger" mechanism might be a universal feature of these complex receptors.
Key Results
- High-Resolution Structure: Achieved a 3.2 Å resolution map of the transmembrane domain and G protein complex.
- Constitutive Activity: They proved the autoinhibition theory by deleting the outer LRR domain. Without this "lid," the receptor became "constitutively active"—meaning it stayed turned "on" even without any hormone present.
- Critical Residues: Mutagenesis confirmed that residues Phe564 and Leu566 in the ECL2 loop are the "fingers" that push the internal signaling button; mutating them completely abolished the receptor's ability to signal.
- Hinge Importance: Identified that the hinge region (specifically residues Leu402 and Leu403) is vital for stabilizing the active conformation of the ECL2 loop.
Limitations and Future Work
- The Missing Link (LDLa): While the study confirms the LDLa module is required for signaling, it was too flexible to be resolved in the cryo-EM maps. Its exact "docking station" on the receptor remains unknown.
- Ectodomain Resolution: Because the outer domains are highly mobile, their resolution was lower (5-8 Å), requiring docking and simulations to fill in the finer details.
- Drug Discovery: The study provides a path for "rational drug design." Future work will focus on whether small-molecule drugs (like the agonist ML290) can bypass the complex hormone-binding machinery to activate the receptor directly via the ECL2 switch.
Summary updated